“…This is particularly true perhaps for the Notch signaling pathway, that has emerged as a popular target in tumor biology both for targeting stem cell phenotypes and aberrant tumor vascularization (Gustafsson et al, 2005;Zeng et al, 2005;Noguera-Troise et al, 2006;Ridgway et al, 2006;Siekmann and Lawson, 2007;Thurston et al, 2007;Bar et al, 2010;Charles et al, 2010;Pistollato et al, 2010b;Yustein et al, 2010). Indeed, there is accumulating evidence that the pseudo-hypoxic phenotype of cancer stem cells itself will lead to increased Notch signaling or specific expression of elements of the Notch signaling pathway, subsequently leading to an increase in both tumor "stemness" and tumor vascularization (Jögi et al, 2002;Gustafsson et al, 2005;Sahlgren et al, 2008;Chen et al, 2010;Eliasz et al, 2010;Pietras et al, 2011).…”